Resectable Clinical N2 Non–Small Cell Lung Cancer; What Is the Optimal Treatment Strategy? An Update by the British Thoracic Society Lung Cancer Specialist Advisory Group
- Resource Type
- Short Communication
- Source
- In
Journal of Thoracic Oncology September 2017 12(9):1434-1441 - Subject
- Language
- ISSN
- 1556-0864